These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1774604)

  • 1. Production of a murine monoclonal antibody with anti-HIV-1 neutralizing properties.
    Hinkula J; Gilljam G; Wahren B
    J Clin Lab Anal; 1991; 5(6):399-405. PubMed ID: 1774604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization.
    Buchacher A; Predl R; Strutzenberger K; Steinfellner W; Trkola A; Purtscher M; Gruber G; Tauer C; Steindl F; Jungbauer A
    AIDS Res Hum Retroviruses; 1994 Apr; 10(4):359-69. PubMed ID: 7520721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological and virological interactions in patients receiving passive immunotherapy with HIV-1 neutralizing monoclonal antibodies.
    Hinkula J; Bratt G; Gilljam G; Nordlund S; Broliden PA; Holmberg V; Olausson-Hansson E; Albert J; Sandström E; Wahren B
    J Acquir Immune Defic Syndr (1988); 1994 Sep; 7(9):940-51. PubMed ID: 8051620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and characterization of chimeric and humanized forms of a broadly neutralizing monoclonal antibody to HIV-1.
    Major JG; Liou RS; Sun LK; Yu LM; Starnes SM; Fung MS; Chang TW; Chang NT
    Hum Antibodies Hybridomas; 1994; 5(1-2):9-17. PubMed ID: 7858187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot-scale production of murine monoclonal antibodies in agitated, ceramic-matrix or hollow-fiber cell culture systems.
    Kurkela R; Fraune E; Vihko P
    Biotechniques; 1993 Oct; 15(4):674-83. PubMed ID: 8251170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.
    D'Souza MP; Geyer SJ; Hanson CV; Hendry RM; Milman G
    AIDS; 1994 Feb; 8(2):169-81. PubMed ID: 7519019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive effects characterize the interaction of antibodies involved in neutralization of the primary dualtropic human immunodeficiency virus type 1 isolate 89.6.
    Verrier F; Nádas A; Gorny MK; Zolla-Pazner S
    J Virol; 2001 Oct; 75(19):9177-86. PubMed ID: 11533181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering and functional evaluation of a single-chain antibody against HIV-1 external glycoprotein gp120.
    Wang HW; Cole D; Jiang WZ; Jin HT; Fu N; Chen ZL; Jin NY
    Clin Exp Immunol; 2005 Jul; 141(1):72-80. PubMed ID: 15958072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of buffering conditions and culture pH on production rates and glycosylation of clinical phase I anti-melanoma mouse IgG3 monoclonal antibody R24.
    Müthing J; Kemminer SE; Conradt HS; Sagi D; Nimtz M; Kärst U; Peter-Katalinić J
    Biotechnol Bioeng; 2003 Aug; 83(3):321-34. PubMed ID: 12783488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mimicking the humoral immune response in vitro results in antigen-specific isotype switching supported by specific autologous T helper cells: generation of human HIV-1-neutralizing IgG monoclonal antibodies from naive donors.
    Chin LT; Malmborg AC; Kristensson K; Hinkula J; Wahren B; Borrebaeck CA
    Eur J Immunol; 1995 Mar; 25(3):657-63. PubMed ID: 7535699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal anti-idiotypic antibody mimicking the principal neutralization site in HIV-1 GP120 induces HIV-1 neutralizing antibodies in rabbits.
    Fung MS; Sun CR; Liou RS; Gordon W; Chang NT; Chang TW; Sun NC
    J Immunol; 1990 Oct; 145(7):2199-206. PubMed ID: 2398276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasma.
    Yuste E; Sanford HB; Carmody J; Bixby J; Little S; Zwick MB; Greenough T; Burton DR; Richman DD; Desrosiers RC; Johnson WE
    J Virol; 2006 Mar; 80(6):3030-41. PubMed ID: 16501112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic neutralization of a chimeric SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulins.
    Li A; Baba TW; Sodroski J; Zolla-Pazner S; Gorny MK; Robinson J; Posner MR; Katinger H; Barbas CF; Burton DR; Chou TC; Ruprecht RM
    AIDS Res Hum Retroviruses; 1997 May; 13(8):647-56. PubMed ID: 9168233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques.
    Jia M; Lu H; Markowitz M; Cheng-Mayer C; Wu X
    J Virol; 2016 Apr; 90(8):4017-4031. PubMed ID: 26842476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variables influencing anti-human immunodeficiency virus type 1 neutralizing human monoclonal antibody (NhMAb) production among infected Thais.
    Akapirat S; Avihingsanon A; Ananworanich J; Schuetz A; Ramasoota P; Luplertlop N; Ono K; Ikuta K; Utachee P; Kameoka M; Leaungwutiwong P
    Southeast Asian J Trop Med Public Health; 2013 Sep; 44(5):825-41. PubMed ID: 24437318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and large production of human monoclonal antibodies against the HIV-1 envelope.
    Boyer V; Broly H; Souche S; Madaule P; Rossier J; Zagury D; Desgranges C
    Clin Exp Immunol; 1991 Mar; 83(3):452-9. PubMed ID: 1706239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of a human anti-CD4 monoclonal antibody with antiidiotype to anti-HIV type 1 glycoprotein 120.
    Karpatkin S; Nardi MA; Liu LX; Kouri YH; Borkowsky W
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):509-15. PubMed ID: 7632465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades.
    Gorny MK; Williams C; Volsky B; Revesz K; Cohen S; Polonis VR; Honnen WJ; Kayman SC; Krachmarov C; Pinter A; Zolla-Pazner S
    J Virol; 2002 Sep; 76(18):9035-45. PubMed ID: 12186887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-idiotype monoclonal antibody elicits broadly neutralizing anti-gp120 antibodies in monkeys.
    Kang CY; Nara P; Chamat S; Caralli V; Chen A; Nguyen ML; Yoshiyama H; Morrow WJ; Ho DD; Köhler H
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2546-50. PubMed ID: 1557358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient laboratory-scale production of monoclonal antibodies using membrane-based high-density cell culture technology.
    Trebak M; Chong JM; Herlyn D; Speicher DW
    J Immunol Methods; 1999 Nov; 230(1-2):59-70. PubMed ID: 10594354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.